Jeffrey Stein
2017
In 2017, Jeffrey Stein earned a total compensation of $1.8M as President and Chief Executive Officer at Cidara Therapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $131,560 |
|---|---|
| Option Awards | $1,232,264 |
| Salary | $460,000 |
| Total | $1,823,824 |
Stein received $1.2M in option awards, accounting for 68% of the total pay in 2017.
Stein also received $131.6K in non-equity incentive plan and $460K in salary.
Rankings
In 2017, Jeffrey Stein's compensation ranked 5,954th out of 14,666 executives tracked by ExecPay. In other words, Stein earned more than 59.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,954 out of 14,666 | 59th |
Division Manufacturing | 2,177 out of 5,772 | 62nd |
Major group Chemicals And Allied Products | 678 out of 2,075 | 67th |
Industry group Drugs | 525 out of 1,731 | 70th |
Industry Biological Products, Except Diagnostic Substances | 94 out of 313 | 70th |
Source: SEC filing on April 27, 2018.
Stein's colleagues
We found three more compensation records of executives who worked with Jeffrey Stein at Cidara Therapeutics in 2017.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019